These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 36560633)

  • 41. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
    Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
    JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
    Kuruppuarachchi KAPP; Jang Y; Seo SH
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk.
    Diexer S; Klee B; Gottschick C; Xu C; Broda A; Purschke O; Binder M; Frese T; Girndt M; Hoell JI; Moor I; Gekle M; Mikolajczyk R
    Int J Infect Dis; 2023 Nov; 136():14-21. PubMed ID: 37634619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proportion of asymptomatic infection and nonsevere disease caused by SARS-CoV-2 Omicron variant: A systematic review and analysis.
    Yu W; Guo Y; Zhang S; Kong Y; Shen Z; Zhang J
    J Med Virol; 2022 Dec; 94(12):5790-5801. PubMed ID: 35961786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant.
    Fernández-de-Las-Peñas C; Cuadrado ML; Gómez-Mayordomo V; García-Azorín D; Arendt-Nielsen L
    Expert Rev Neurother; 2023 Feb; 23(2):179-186. PubMed ID: 36857191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2.
    Hirotsu Y; Kakizaki Y; Saito A; Tsutsui T; Hanawa S; Yamaki H; Ide S; Kawaguchi M; Kobayashi H; Miyashita Y; Omata M
    Commun Med (Lond); 2023 Feb; 3(1):32. PubMed ID: 36841870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review.
    Fericean RM; Oancea C; Reddyreddy AR; Rosca O; Bratosin F; Bloanca V; Citu C; Alambaram S; Vasamsetti NG; Dumitru C
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omicron variant genome evolution and phylogenetics.
    Kandeel M; Mohamed MEM; Abd El-Lateef HM; Venugopala KN; El-Beltagi HS
    J Med Virol; 2022 Apr; 94(4):1627-1632. PubMed ID: 34888894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors.
    Saigal A; Nagoda Niklewicz C; Naidu SB; Bintalib HM; Shah AJ; Seligmann G; Hunter AS; Wey E; Abubakar I; Mahungu T; Miller D; Barnett J; Jain NG; Brill S; Goldring J; Jarvis H; Smith C; Ogbonnaya C; Hurst JR; Lipman MCI; Mandal S
    BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37536948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.
    Khemiri H; Ayouni K; Triki H; Haddad-Boubaker S
    Virol J; 2022 Sep; 19(1):144. PubMed ID: 36076271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.